title: Addition of suberoylanilide hydroxamic acid (Vorinostat) to azacitidine for patients with higher risk myelodysplastic syndromes and azacitidine failure: a phase II add-on study from the Groupe Francophone des Myelodysplasies.
authors.affiliation: Haematology Department, Institut PAOLI-CALMETTES and Aix-Marseille Université, Marseille, France.|Section of Hematology, Department of Internal Medicine, Yale University, New Haven, CT, USA.
authors.forename: Thomas
authors.identifier: 0000-0002-6872-625X
authors.initials: T
authors.lastname: Prebet
authors.affiliation: Haematology Department, Centre Hospitalo universitaire, Nantes, France.
authors.forename: Jacques
authors.initials: J
authors.lastname: Delaunay
authors.affiliation: Haematology Department, Hôpital Lyon Sud, Pierre-Bénite, France.
authors.forename: Eric
authors.initials: E
authors.lastname: Wattel
authors.affiliation: Haematology Department, Hôpital Avicenne, Bobigny, France.|Assistance Publique Hopitaux de Paris (AP-HP), Paris, France.
authors.forename: Thorsten
authors.initials: T
authors.lastname: Braun
authors.affiliation: Haematology Department, Centre Hospitalier Annecy, Pringy, France.
authors.forename: Pascale
authors.initials: P
authors.lastname: Cony-Makhoul
authors.affiliation: Haematology Department, Centre Hospitalo Unversitaire Tripode, Pessac, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Dimicoli
authors.affiliation: Haematology Department, Centre Hospitalo universitaire, Nimes, France.
authors.forename: Stephan
authors.initials: S
authors.lastname: Wickenhauser
authors.affiliation: Assistance Publique Hopitaux de Paris (AP-HP), Paris, France.|Biostatistic Department, Hôpital Saint Louis, Paris, France.
authors.forename: Julie
authors.initials: J
authors.lastname: Lejeune
authors.affiliation: Assistance Publique Hopitaux de Paris (AP-HP), Paris, France.|Biostatistic Department, Hôpital Saint Louis, Paris, France.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Chevret
authors.affiliation: Assistance Publique Hopitaux de Paris (AP-HP), Paris, France.|Haematology Department, Hôpital Saint Louis, Paris, France.
authors.forename: Fatiha
authors.initials: F
authors.lastname: Chermat
authors.affiliation: Assistance Publique Hopitaux de Paris (AP-HP), Paris, France.|Haematology Department, Hôpital Saint Louis, Paris, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Fenaux
authors.affiliation: Haematology Department, Institut PAOLI-CALMETTES and Aix-Marseille Université, Marseille, France.
authors.forename: Norbert
authors.initials: N
authors.lastname: Vey
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage; D018572:Disease-Free Survival; D006801:Humans; D053208:Kaplan-Meier Estimate; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000401:mortality; D012307:Risk Factors; D016896:Treatment Outcome; D000077337:Vorinostat / Q000008:administration & dosage
chemical_list: D000077337:Vorinostat; D001374:Azacitidine
keywords: epigenetic; myelodysplasia; myeloid leukaemia; relapse